PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33922395-7	2021	Moreover, ellagic acid (EA) inhibited the TGF-beta signaling pathway both in vitro and in vivo by reducing Smad2, Smad3, and Smad4 expression and thereby resensitized GCB sensitivity.	Ellagic Acid	10-22	SMAD family member 3	Homo sapiens	114-119	
32468010-0	2020	Ellagic acid induces cell cycle arrest and apoptosis via the TGF-beta1/Smad3 signaling pathway in human colon cancer HCT-116 cells.	Ellagic Acid	0-12	SMAD family member 3	Homo sapiens	71-76	
25647396-0	2015	Ellagic acid induces cell cycle arrest and apoptosis through TGF-beta/Smad3 signaling pathway in human breast cancer MCF-7 cells.	Ellagic Acid	0-12	SMAD family member 3	Homo sapiens	70-75	
24528038-0	2014	Ellagic acid exerts anti-proliferation effects via modulation of Tgf-beta/Smad3 signaling in MCF-7 breast cancer cells.	Ellagic Acid	0-12	SMAD family member 3	Homo sapiens	74-79	
24528038-3	2014	In this study, our aim was to investigate whether ellagic acid inhibits the proliferation of MCF- 7 human breast cancer cells via regulation of the TGF-beta/Smad3 signaling pathway.	Ellagic Acid	50-62	SMAD family member 3	Homo sapiens	157-162	
24528038-9	2014	Moreover, SIS3 reversed the effects of ellagic acid on the expression of downstream targets of the TGF-beta/Smad3 pathway.	Ellagic Acid	39-51	SMAD family member 3	Homo sapiens	108-113	
24528038-10	2014	In conclusion, ellagic acid leads to decreased phosphorylation of RB proteins mainly through modulation of the TGF-beta/Smad3 pathway, and thereby inhibits the proliferation of MCF-7 breast cancer cells.	Ellagic Acid	15-27	SMAD family member 3	Homo sapiens	120-125	
33922395-7	2021	Moreover, ellagic acid (EA) inhibited the TGF-beta signaling pathway both in vitro and in vivo by reducing Smad2, Smad3, and Smad4 expression and thereby resensitized GCB sensitivity.	Ellagic Acid	24-26	SMAD family member 3	Homo sapiens	114-119